Oxeltra 40mg modified-release tablets
BNF presentation 0407020ADBLAEAH within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
0407020ADBLAEAH
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
3,099
NHS spend (£)
£63,435.22
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 384 |
| February 2025 | 1 |
| December 2024 | 110 |
| November 2024 | 450 |
| October 2024 | 467 |
| September 2024 | 3 |
| August 2024 | 41 |
| July 2024 | 466 |
| May 2024 | 117 |
| July 2021 | 173 |
| June 2021 | 98 |
| December 2020 | 346 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 44 | No data available |
| Unknown pharmacy | 36 | No data available |
| Unknown pharmacy | 31 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 26 | No data available |
| Unknown pharmacy | 24 | No data available |
| Unknown pharmacy | 24 | No data available |
|
Market Cross Surgery
ODS D83018
|
23 | 07K - SUFFOLK AND NORTH EAST ESSEX ICB |
| Unknown pharmacy | 23 | No data available |